🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to see if these T-lymphocytes are safe. T...
Status
Completed
Location
National Institute of Health (NIH)
Start Date
2003-07
Trial ID
NCT00590083
Treatments Being Tested
This Phase I dose-escalation trial is designed to evaluate the safety of ra...
Status
Active Not Recruiting
Location
Childrens National Medical Center
Start Date
2017-02-15
Trial ID
NCT03180216
Treatments Being Tested
The investigators want to learn if CMV- and ADV-specific T-cells (cells tha...
Status
Recruiting
Location
St . Jude Children's Research Hospital
Start Date
2023-08-01
Trial ID
NCT05664126
Treatments Being Tested
This phase I trial studies the side effects of allogeneic adenovirus-specif...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-03-15
Trial ID
NCT03425526
Treatments Being Tested
Fourteen patients will be included for infusion of adenovirus-specific T-ce...
Status
Completed
Location
Centre Hospitalier Universitaire de Nancy
Start Date
2011-08
Trial ID
NCT02851576
Treatments Being Tested
The purpose of this study is to evaluate whether virus-specific T cell line...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Start Date
2018-06-20
Trial ID
NCT03475212
Treatments Being Tested
This is a Phase 3 study to evaluate posoleucel (ALVR105, Viralym-M); an all...
Status
Terminated
Location
University of Alabama at Birmingham Children's of Alabama
Start Date
2022-03-24
Trial ID
NCT05305040
Treatments Being Tested
The purpose of the study is to determine the feasibility, safety and effica...
Status
Completed
Location
University General Hospital of Patras
Start Date
2021-05-22
Trial ID
NCT05471661
Treatments Being Tested
RATIONALE: Because of its success in advanced NSCLC both as a single agent ...
Status
Terminated
Location
M.D. Anderson Cancer Center, Orlando
Start Date
2004-02
Trial ID
NCT00664105
Treatments Being Tested
To assess the feasibility of donor-derived interferon (IFN)-γ positive sele...
Status
Recruiting
Location
Universitätsspital Basel
Start Date
2014-12
Trial ID
NCT02007356
Treatments Being Tested